Features of the management and follow-up of a "difficult" comorbid elderly patient with COVID-19 complications: a clinical case

Background. The SARS-CoV-2 virus, penetrating through the respiratory tract, causes polysystemic inflammation and damage to many organs and tissues of the human body. In 2020, the term “Long-COVID” appeared, as well as NICE recommendations for its management; in October 2021, WHO gave the official definition of “post-COVID-19 syndrome”. To date, however, most questions related to the course of the disease and prognosis after a new coronavirus infection have remained open. Description of the clinical case. A clinical case of observation of an elderly patient with the manifestation of COVID-19 in the form of a combined lesion of the bronchopulmonary (viral pneumonia, CT-2, 40% lesion), cardiovascular (viral myocarditis and cardiomyopathy with the development of paroxysmal tachysystolic atrial fibrillation), genitourinary system (acute urinary retention against the background of benign prostatic hyperplasia), and skin (viral exanthema) is presented. Taking into account the severity of the patient’s post-COVID-19 somatic condition, a long-term (more than six months) period of stabilization and rehabilitation was required for successful planned surgical urological treatment and improving the quality of life of the «difficult» patient. Conclusion. The presented clinical case shows that the use of antihypoxants-antioxidants and metabolic drugs is recommended in order to alleviate the course of the disease and overcome the consequences of the COVID-19 infection (individual in each case).

new coronavirus infection (COVID-19), complications andpost-COVID syndrome (“Long-COVID"), elderly (senile) age, acute urinary retention, atrial fibrillation, antihypoxants, antioxidants and metabolic drugs